EP2218461
CD40 antibody formulation and methods
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
9.12.2004EP published:
20.4.2016EP application number:
10162787.5
EPO information:
European Patent Register
Max expiry date:
8.12.2024
Title:
CD40 antibody formulation and methods
Timeline
Today
9.12.2004EP application
20.4.2016EP Publication
Owner
Name:
Pfizer Products Inc.Address:
Eastern Point Road, 06340, Groton, CT, US
Inventor
Name:
Bedian, VaheAddress:
Groton, CT, US
Name:
Cusmano, John, DanielAddress:
Groton, CT, US
Name:
Gladue, Ronald, PaulAddress:
Groton, CT, US
Priority
Number:
531639 PDate:
22.12.2003Country:
US
Classification
Categories:
A61K 39/395, A61P 35/00, C07K 16/28, A61K 39/00, A61K 31/00